摘要
目的探讨以聚合酶链式反应(PCR)为基础的高危型人乳头瘤病毒(HPV)分型检测在宫颈癌筛查中的应用和诊断价值。方法选取2016年6月至2019年6月西安航天医院收治的疑似宫颈病变病人628例,分别采取高危型HPV分型PCR技术(HR-HPVDNAPCR),液基薄层细胞学检查(TCT)以及病理组织活检诊断,以病理活检作为诊断宫颈病变的“金标准”,分析高危型HPV感染与宫颈病变的关系以及高危型HPV分型检测技术在宫颈癌筛查中的应用价值。结果HR-HPVDNAPCR技术的灵敏度为91.76%,特异度为91.29%,阳性预测值为9356%,阴性预测值为88.93%,符合率为91.56%,均显著优于TCT检测方法(P<0.001)。同时,对13种HPV亚型分析发现,16、18亚型与宫颈癌及癌前病变密切相关(P<0.05),33、52及58型次之(P<0.05)。而且,HPV的感染率随着年龄的增长而增长,>39~49岁病人HPV感染率为58.15%、>49~59岁病人为64.29%、>59岁病人为75.41%,均显著高于20~29岁的年轻病人的46.40%(P<0.05)。结论高危型HPV持续感染是宫颈癌及癌前病变发生的关键因素,以PCR为基础的高危型HPV分型检测在宫颈癌筛查中具有较高的应用价值。
Objective To investigate the application and diagnostic value of high-risk human papillomavirus(HPV)typing based on polymerase chain reaction(PCR)in the screening of cervical cancer and precancerous lesions.Methods A total of 628 patients with suspected cervical lesions admitted to Xi'an Aerospace General Hospital from June 2016 to June 2019 were selected.High-risk HPV typing PCR(HR-HPV DNA PCR),thinprep cytology test(TCT)and pathological biopsy were used for diagnosis,and pathological diagnosis was used as the"gold standard"for the diagnosis of cervical lesions.The relationship between high-risk HPV infection and cervical lesions was analyzed.Results The sensitivity of HR-HPV DNA PCR technology was 91.76%,the specificity was 91.29%,the positive predictive value was 9356%,the negative predictive rate was 88.93%,and the coincidence rate was 91.56%,which were significantly better than those of the TCT detection method(P<0.001).In addition,13 HPV subtypes were found,16 and 18 subtypes and cervix cancer and precancerous lesions were closely related(P<0.05),followed by 33,52 and 58 subtypes(P<0.05).Moreover,the HPV infection rate increased with age.The HPV infection rate was 58.15%for patients aged>39-49 years,64.29%for patients>49-59 years old,and 75.41%for patients>59 years old,which were significantly higher than 46.40%of young patients aged 20-29(P<0.05).Conclusions High-risk HPV infection is a key factor in the development of cervical cancer and precancerous lesions.High-risk HPV typing has a high value in the screening of cervical cancer and precancerous lesions.
作者
蔡江义
崔旭
秦岭
康媛媛
白焕焕
CAI Jiangyi;CUI Xu;QIN Ling;KANG Yuanyuan;BAI Huanhuan(Department of Pathology,Xi'an General Aerospace Hospital,Xi'an,Shaanxi 710000,China;Department of Pathology,Weinan Central Hospital,Weinan,Shaanxi 714000,China;Department of Pathology,Xi'an Fengcheng Hospital,Xi'an,Shaanxi 710000,China;Department of Pathology,Jingbian People's Hospital,Yulin,Shaanxi 719000,China;Department of Pathology,Yulin Traditional Chinese Medicine Hospital,Yulin,Shaanxi 719000,China)
出处
《安徽医药》
CAS
2021年第9期1839-1842,共4页
Anhui Medical and Pharmaceutical Journal